In March 2025, the company introduced new plans for just a immediate-to-buyer giving of its Wegovy weight loss drug. The company recognized a completely new pharmacy, referred to as NovoCare, which would charge consumers $499 monthly for entry to the drug, less than 50 percent the cost of the drug through other pharmaceutical distribution networks.